APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 35 filers reported holding APREA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $107,925 | -51.8% | 335,276 | -2.5% | 0.00% | – |
| Q3 2022 | $224,000 | -23.8% | 343,900 | -13.3% | 0.00% | – |
| Q2 2022 | $294,000 | -64.4% | 396,781 | -10.7% | 0.00% | – |
| Q1 2022 | $826,000 | -6.6% | 444,282 | +44.5% | 0.00% | – |
| Q4 2021 | $884,000 | -37.3% | 307,561 | +11.4% | 0.00% | – |
| Q3 2021 | $1,411,000 | +214.3% | 276,149 | +200.4% | 0.00% | – |
| Q2 2021 | $449,000 | +116.9% | 91,919 | +127.0% | 0.00% | – |
| Q1 2021 | $207,000 | -88.4% | 40,500 | -45.3% | 0.00% | -100.0% |
| Q3 2020 | $1,783,000 | -85.1% | 74,073 | -76.0% | 0.00% | -75.0% |
| Q2 2020 | $11,981,000 | +7.3% | 308,948 | -3.8% | 0.00% | -20.0% |
| Q1 2020 | $11,166,000 | -21.3% | 321,241 | +4.0% | 0.01% | -16.7% |
| Q4 2019 | $14,181,000 | – | 309,012 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,259,662 | $6,437,000 | 2.66% |
| COASTAL INVESTMENT MANAGEMENT, L.P. | 41,965 | $214,000 | 0.30% |
| Redmile Group, LLC | 694,918 | $3,551,000 | 0.06% |
| Quantamental Technologies LLC | 13,752 | $70,000 | 0.05% |
| KENNEDY CAPITAL MANAGEMENT LLC | 342,486 | $1,750,000 | 0.04% |
| PDT Partners, LLC | 87,734 | $448,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 75,000 | $383,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 49,100 | $251,000 | 0.01% |
| NEXT Financial Group, Inc | 11,347 | $58,000 | 0.01% |
| Sugarloaf Wealth Management, LLC | 1,500 | $8,000 | 0.00% |